Institutional shares held 107 Million
555K calls
177K puts
Total value of holdings $359M
$1.86M calls
$591K puts
Market Cap $253M
75,683,696 Shares Out.
Institutional ownership 141.95%
# of Institutions 256


Latest Institutional Activity in RCKT

Top Purchases

Q2 2025
111 Capital Shares Held: 22.6K ($75.5K)
Q2 2025
Farther Finance Advisors, LLC Shares Held: 13.5K ($45.2K)
Q2 2025
Pfg Investments, LLC Shares Held: 18.1K ($60.5K)
Q2 2025
Mirae Asset Global Investments Co., Ltd. Shares Held: 4.16K ($13.9K)
Q2 2025
Gamma Investing LLC Shares Held: 830 ($2.77K)

Top Sells

Q2 2025
Sovran Advisors, LLC Shares Held: 196K ($655K)
Q2 2025
Signaturefd, LLC Shares Held: 3.56K ($11.9K)
Q2 2025
Parallel Advisors, LLC Shares Held: 230 ($768)
Q2 2025
Massmutual Trust CO Fsb Shares Held: 442 ($1.48K)
Q1 2025
Citadel Advisors LLC Shares Held: 1.51M ($5.04M)

About RCKT

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.


Insider Transactions at RCKT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
808K Shares
From 18 Insiders
Grant, award, or other acquisition 752K shares
Other acquisition or disposition 14.2K shares
Open market or private purchase 41.1K shares
Sell / Disposition
103K Shares
From 7 Insiders
Open market or private sale 103K shares

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT